Navigation Links
Protege Encore Clinical Trial Evaluates New Investigational Approach For Individuals Recently Diagnosed With Type 1 Diabetes
Date:5/10/2010

WELLINGTON, Fla., May 10 /PRNewswire-USNewswire/ -- Dr. Richard Hays announced today that he is now recruiting children with newly diagnosed type 1 diabetes for Protege Encore, a randomized, placebo-controlled Phase III clinical trial. This is the second of two Phase III studies testing the safety and efficacy of an investigational drug called teplizumab. The first study, known as Protege, has completed enrollment of more than 530 subjects with type 1 diabetes. There is currently no approved therapy to slow the progression of type 1 diabetes.

In patients with type 1 diabetes, T cells of the immune system attack and destroy beta cells that are located in the pancreas and make insulin. Teplizumab works by binding to CD3 receptors on the surface of the T cells and, by doing so, may modulate the autoimmune attack on pancreatic beta cells and preserve or protect these cells. If effective, patients may require less injected insulin and their blood glucose levels may be easier to control.

In an earlier trial of teplizumab, a small group of subjects with diabetes of recent onset were noted to have improved function of their beta cells, improved glucose control, and reduced insulin requirements for up to two years. These findings are being further studied in the Protege and Protege Encore clinical trials.

The Protege Encore trial is designed to determine if teplizumab can preserve pancreatic insulin production, which may make diabetes easier to manage. "We have a lot of enthusiasm about the teplizumab studies and their implications. It is hoped that one day we can offer a new treatment option to help patients better manage their disease," Dr. Hays commented.

Approximately 125 study sites across 16 countries will be enrolling 400
'/>"/>

SOURCE Richard M. Hays, M.D., P.A.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. MacroGenics and Lilly Achieve Targeted Patient Enrollment in PROTEGE, a Global Phase 2/3 Clinical Trial of Teplizumab in Type 1 Diabetes
2. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
3. Novocell Becomes ViaCyte, Inc., as it Accelerates Pre-Clinical Development of a Stem Cell Derived Treatment for Diabetes
4. Stereotaxis Updates Progress on Major Clinical Initiative Related to Electrophysiology (EP) Treatment of Ventricular Tachycardia
5. US HIFU Receives Unanimous Approval to Continue the Clinical Investigation of High Intensity Focused Ultrasound (HIFU) for Treatment of Prostate Cancer
6. Lexicon to Provide Clinical Pipeline Update and Report First Quarter 2010 Financial Results
7. Omeros Reports Additional Phase 2 Data Showing Multiple Clinical Benefits In Patients Undergoing Meniscectomy Surgery
8. US Oncology Meets With Leading Pharmaceutical and Biotech Companies to Design Clinical Trials for the Cancer Fighting Drugs of Tomorrow
9. OrbusNeichs Genous(TM) Bio-engineered R stent(TM) Demonstrates Excellent Safety and Clinical Outcomes in High-Risk Elderly Patients
10. Lotus Pharmaceuticals Laevo-Bambuterol Received SFDA Approval to Commence Clinical Trials
11. Novavaxs Seasonal Influenza VLP Vaccine Candidate Shows Positive Results in a Phase II Clinical Trial in Older Adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... 2014 Australian biomarker discovery company Minomic International ... its MiStat™ prostate cancer screening test, planning to achieve ... completion. Minomic,s proprietary MiStat™ technology is a ... proprietary biomarker known as the MIL-38 antigen. This biomarker ... Researchers at 11 leading urology centres ...
(Date:9/18/2014)... YORK , Sept. 18, 2014 Relmada ... therapies for the treatment of chronic pain, announced today ... to the position of  Senior Director of Clinical ... Research, Mr. James has established and led successful global ... Europe , to facilitate the clinical development of ...
(Date:9/18/2014)... , Sept. 18, 2014  Spring Bank ... therapeutics for the treatment of RNA viruses, today ... of Health (NIH) for animal testing of the ... pathogens, classified as "Special Pathogens," against which currently ... derived from Spring Bank,s proprietary Small ...
Breaking Medicine Technology:Minomic Launches US Pilot Study of MiStat(TM) Novel Prostate Cancer Screening Technology 2Relmada Therapeutics, Inc. Appoints Christopher W. James As Senior Director of Clinical Development 2Spring Bank Pharmaceuticals Announces NIH Collaboration for Testing of SB 9200 Against Multiple Viral Pathogens 2
... Feb. 16, 2012 Millstone Medical Outsourcing announced today ... CA, and Warsaw, IN.  With new offices positioned in ... will be able to provide customer-specific program development as ... Senior Vice President, will run the San Diego office, ...
... Inc. (PSI), a leading pharmaceutical CRO, announced today that ... oral formulation efforts.  According to Mark Mitchnick, the company,s ... technologies applicable across many dosage forms and drug types.  ... on small molecules of which about 80% fall into ...
Cached Medicine Technology:Millstone Medical Outsourcing Opens Sales Offices in CA, IN 2Particle Sciences Hires Robert Gwozdz to Head Oral Formulation 2
(Date:9/18/2014)... the popular online supplier of funny figurines, has added a ... line. Moreover, all the company’s products are now offered with ... special offer before September 29, 2014. Customers who place bulk ... bobblehead doll ). , “We are pleased to ... make our interesting items available to all the global customers. ...
(Date:9/18/2014)... Hills, CA (PRWEB) September 18, 2014 ... camp, is the fastest-selling fitness business in the country and ... work out, has continued to grow enormously in 2014. ... Camp World Conference, is taking place in Costa Mesa, CA ... one of the biggest conferences yet. Founder Bedros Keuilian, who ...
(Date:9/18/2014)... A positive outlook on life can go ... This year, at the Weekend for Women Conference in Los ... radio talk show host Mother Love will be speaking on ... , The always-funny Jo Anne Hart, aka Mother Love, has ... her widely acclaimed talk show on LATalkRadio.com, which airs weekdays ...
(Date:9/18/2014)... September 18, 2014 How much is ... one of the factors contributing to the obesity epidemic ... a single serving and how to manage portion size ... presentation Oct. 3 at Humility House, 755 Ohltown Road, ... will lead the informational discussion and answer questions from ...
(Date:9/18/2014)... It is true that a business-oriented ... a successful brand or business online. Best Cheap ... compared plenty of professional web hosting suppliers and ... iPage are the best VPS hosting suppliers in ... hosting. All-sized businesses or enterprises can find the ...
Breaking Medicine News(10 mins):Health News:Discounted Custom Bobbleheads Online For Sale At WowBobble.com 2Health News:With Fit Body Boot Camp World Conference Nearing, Founder Explains the Fitness Boot Camp Franchise’s Success 2Health News:With Fit Body Boot Camp World Conference Nearing, Founder Explains the Fitness Boot Camp Franchise’s Success 3Health News:DiabetesSisters Showcases Radio Talk Show Host Mother Love at Weekend for Women Conference in Los Angeles 2Health News:HMHP Workshop Addresses Portion Control 2Health News:Best Cheap Hosting USA: GreenGeeks, Arvixe And iPage Are The Best Hosting Suppliers In 2014 2
... last year when he gave the slip to authorities after being ... ailing son. ,He has now been captured, along with ... in Puerto Vallarta on Mexico's Pacific coast, said Deputy U.S. Marshal ... by a federal judge in January 2006 so he could complete ...
... burst into the open in Paris, Dr. Brian Halevie-Goldman, ... months by the// Californian state authorities. ,Dr.Goldman ... Laboratory Co-Operative that allegedly provided steroids to top athletes. ... years' probation and ordered to undergo a psychiatric evaluation ...
... abalone are paying with their lives. Four people perished in ... used in sushi// and a variety of other Asian dishes ... market. ,Abalone are a special type of shellfish ... delicacy in certain parts of Latin America (especially Chile), South ...
... consumer court in Himachal Pradesh has fined the soft drink ... a consumer five years ago//. The complaint was lodged after ... ,The Himachal Pradesh Consumer Redressal Commission here Tuesday asked ... in 2002 by a consumer in Dharamsala, 280 km from ...
... not only protects memories from outside interferences, but also ... looked at memory recall with and without interference (competing ... 30 took part in the study. All had normal, ... Participants were divided evenly into four groups—a wake group ...
... of the body’s genetic repair system may cause Huntington’s ... by destroying their nervous system. Until now, no one ... ,"We showed that when single-strand breaks in ... gene continued to add extra replacement segments," explains Cynthia ...
Cached Medicine News:Health News:Fugitive Who Ditched His Ailing Son Arrested After a Year 2Health News:US Psychiatrist Suspended from Practicing Medicine for Involvement in Doping Scam 2Health News:US Psychiatrist Suspended from Practicing Medicine for Involvement in Doping Scam 3Health News:Hunt for Sea Delicacy Taking a Toll in California 2Health News:Hunt for Sea Delicacy Taking a Toll in California 3Health News:Sleep Makes Your Memory Strong 2Health News:Researchers Discovers DNA Repair as Key to Huntington's Disease 2
Hydrophobic PE filter without self-sealing additives, permits sample recovery after accidental over-pipetting. All filters are sterile (to USP, DAB, Ph.Eur. standards) and PCR clean (free from human ...
Ideal for use with low volume samples on the Biomek robotic pipetting systems, the ART 20R provides guaranteed protection for your expensive workstation....
... eliminate false signals and contamination caused ... Promega Barrier Tips offer performance and ... acids (PCR(a)), radioactive isotopes, tissue culture ... specimens. , ,Promega Barrier Tips are ...
... 0.5l - 10l Eppendorf Barrier Tips. Designed to ... reduces the amount of DNA and proteins bound ... advertised as low retention, which means the focus ... tip. However, AvantGard also focuses on low binding ...
Medicine Products: